Biotechnology company · Haddonfield, New Jersey, United States
Research grants: $798,670 View profile Medical device company · Seattle, Washington, United States
Research grants: $449,716 View profile Biotechnology company · Princeton, New Jersey, United States
Research grants: $625,268 View profile Biotechnology company · Tempe, Arizona, United States
Private funding (2017) 1 clinical trial Founded 2014 View profile Medical device company · Jacksonville, Florida, United States
Research grants: $613,744 View profile Biotechnology company · Awendaw, South Carolina, United States
Research grants: $448,562 View profile Medical device company · El Segundo, California, United States
1 clinical trial Research grants: $150,000 View profile Biotechnology company · Philadelphia, Pennsylvania, United States
Research grants: $586,810 View profile Biotechnology company · Palm Springs, California, United States
Research grants: $617,300 View profile Medical device company · Rochester Hills, Michigan, United States
NYSE: INFU
View profile Medical device company · San Carlos, California, United States
1 clinical trial Research grants: $48,626 View profile Biotechnology company · Lebanon, New Hampshire, United States
Research grants: $592,708 View profile Biotechnology company · Rockville, Maryland, United States
Research grants: $434,308 View profile Contract research organization (CRO) · Netherlands
On BioBridgeX
View profile Biotechnology company · San Jose, California, United States
Research grants: $955,078 View profile Biotechnology company · Brooklyn, New York, United States
Research grants: $4 million View profile Medical device company · Beltsville, Maryland, United States
Raised $25,000 (2013) 1 clinical trial Founded 2012 View profile Medical device company · Cincinnati, Ohio, United States
Research grants: $551,058 View profile Medical device company · Longmont, Colorado, United States
Research grants: $465,002 View profile Medical device company · Marietta, Georgia, United States
Research grants: $650,816 View profile